Frontiers in Oncology | Hematologic Malignancies

Case Report

Published on 21 Jan 2025

Alectinib combined with VRCD and BV monoclonal antibody for the treatment of ALK-positive large B-cell lymphoma: a case report and literature review

in Hematologic Malignancies

Hongxia Wang
Junjun Bai
Bei Zhang
Zhixin Pei
Yingxin Zhao
Jingjing Gu
Zhiyu Fang
Miaomiao Liu
Xun Liang
Qinglin Song

Frontiers in Oncology

doi 10.3389/fonc.2024.1480880

2,025 views
1 citation

Systematic Review

Published on 21 Jan 2025

Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia

in Hematologic Malignancies

P. Joy Ho
Hang Quach
M. Hasib Sidiqi
Cindy H. Lee
Jason Butler
Andrew Spencer
Kenneth Micklethwaite
Jingya Li
Elissa Cusson
Robert Bagnall

Frontiers in Oncology

doi 10.3389/fonc.2024.1535869

6,139 views
1 citation

Original Research

Published on 21 Jan 2025

Transcription factor KLF2 is associated with the dysfunctional status of NK cells and the prognosis of pediatric B-ALL patients

in Hematologic Malignancies

Fang Wu
Huimin Xu
Benshan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1456004

2,340 views
1 citation

Review

Published on 20 Jan 2025

Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia

in Hematologic Malignancies

Elissa Tjahjono
Megan R. Daneman
Bernadetta Meika
Alexey V. Revtovich
Natalia V. Kirienko

Frontiers in Oncology

doi 10.3389/fonc.2024.1532857

4,483 views
6 citations

Review

Published on 16 Jan 2025

Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma

in Hematologic Malignancies

Hong Yan
Nan Jiang
Xiaoying Li
Chenyang Lin
Fang Wang
Juan Zhang
Lijuan Chen
Dan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1522491

2,664 views
2 citations

Original Research

Published on 07 Jan 2025

Real-world experiences with brentuximab vedotion-based regimens in systemic anaplastic large cell lymphoma: a multi-center retrospective study

in Hematologic Malignancies

Zhiqiang Zhao
Qinchuan Yu
Liping Su
Jianxia He
Jie Tao
Yanfeng Xi
Yujiao Guo
Yanhong Luo
Lieyang Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1494384

3,025 views
1 citation

Systematic Review

Published on 07 Jan 2025

The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis

in Hematologic Malignancies

Jile Liu
Yuxin An
Rui Sun
Xiaomei Zhang
Shujing Guo
Xuejin Gao
Mingfeng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1478888

4,501 views
1 citation

Original Research

Published on 07 Jan 2025

Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML

in Hematologic Malignancies

Petra Bašová
Lubomír Minařík
Silvia Carina Magalhaes-Novais
Jana Balounová
Zuzana Zemanová
Tatiana Aghová
Martin Špaček
Anna Jonášová
Kristýna Gloc Pimková
Jan Procházka

Frontiers in Oncology

doi 10.3389/fonc.2024.1414950

3,681 views

Original Research

Published on 06 Jan 2025

Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes

in Hematologic Malignancies

Lisa Dietsche
Kristin Stirm
Veronika Lysenko
Corina Schneidawind
Alexandar Tzankov
Anne Müller
Alexandre P. A. Theocharides

Frontiers in Oncology

doi 10.3389/fonc.2024.1481713

2,729 views
1 citation

Editorial

Published on 06 Jan 2025

Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment, volume II

in Hematologic Malignancies

Lokman Varisli
Garrett M. Dancik
John A. Copland
Spiros A. Vlahopoulos

Frontiers in Oncology

doi 10.3389/fonc.2024.1542306

1,135 views
1 citation

Original Research

Published on 06 Jan 2025

Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma

in Hematologic Malignancies

Dan Liu
Xia Yin
Hui Wang
Lijie Xing
Ping Li
Haichen Wei
Ji Ma
Qiang He
Linna Xie
Ke Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1504809

1,850 views

Original Research

Published on 06 Jan 2025

Outcome of critically ill patients receiving systemic chemotherapy on the intensive care unit

in Hematologic Malignancies

Panagiotis Karagiannis
Felix Klingler
Viktor Arelin
Winfried Alsdorf
Christina König
Kevin Roedl
Walter Fiedler
Katja Weisel
Stefan Kluge
Carsten Bokemeyer

Frontiers in Oncology

doi 10.3389/fonc.2024.1508112

2,963 views
1 citation

Case Report

Published on 06 Jan 2025

Case report: a 3-year follow-up on nodal marginal zone lymphoma coexisting with disseminated Talaromyces marneffei infection in a non-endemic area

in Hematologic Malignancies

Xiping Yu
Houyun Xu
Junjie Zhou
Zhiqiang Zhu
Baizhou Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1407893

1,382 views
3 citations

Review

Published on 24 Dec 2024

BTK inhibition in primary central nervous system lymphoma: mechanisms, clinical efficacy, and future perspectives

in Hematologic Malignancies

Yurou Xing
Kejia Zhao
Yi Zhang
Yongsheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1463505

3,999 views
3 citations

Case Report

Published on 19 Dec 2024

Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports

in Hematologic Malignancies

Yunshuo Xiao
Kun Yang
Qiuying Huang
Changqing Wei
Manlv Wei
Zhili Geng
Hui Wu
Tianhong Zhou
Xialoin Yin
Yali Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1477697

2,297 views
2 citations

Case Report

Published on 17 Dec 2024

Obinutuzumab-induced acute thrombocytopenia: a case report and literature review

in Hematologic Malignancies

Xuelin Dou
Kongyang Li
Jin Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1509567

2,302 views
1 citation

Clinical Trial

Published on 16 Dec 2024

A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma

in Hematologic Malignancies

Jeffrey J. Pu
Kristin N. Berger
Chunlei Zheng
Nhan Do
David F. Claxton
W. Christopher Ehmann
Joseph J. Drabick
Haiquan Li
Thomas P. Loughran
Elliot M. Epner

Frontiers in Oncology

doi 10.3389/fonc.2024.1449401

2,306 views

Case Report

Published on 12 Dec 2024

Chronic myelogenous leukemia coexpressing V-e16a2, V-e13a2, e13a2, and e14a2 BCR::ABL1 fusion transcripts: a case report and review of the literature

in Hematologic Malignancies

Yang Xu
Yuying Fan
Sijin Liu
Jianmei Chang
Caifeng Guo
Lanhui Chen
Wenzheng Guo
Jinwen Dang
Hongwei Wang
Yanhong Tan

Frontiers in Oncology

doi 10.3389/fonc.2024.1518387

1,449 views

Correction

Published on 11 Dec 2024

Corrigendum: Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool

in Hematologic Malignancies

Lina U. Ivert
Anna H. Winther
Pontus Jonsson
Hanna Brauner

Frontiers in Oncology

doi 10.3389/fonc.2024.1504102

951 views

Case Report

Published on 11 Dec 2024

Preoperative diagnosis of primary ovarian lymphoma: a case report and a decade of insights

in Hematologic Malignancies

Wei Liu
Houyun Xu
Jibo Hu
Xiping Yu
Junjie Zhou
Hongjie Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1471654

1,348 views

Case Report

Published on 10 Dec 2024

Severe atypical skin disease in two patients with CLL/SLL after BTKi treatment - a case report and literature review

in Hematologic Malignancies

Jingxin Zhou
Wentong Ma
Na Hu
Yuhan Ma
Huayuan Zhu
Ling Gao

Frontiers in Oncology

doi 10.3389/fonc.2024.1467891

1,872 views
1 citation

Case Report

Published on 10 Dec 2024

Case report: Identification of a novel TOR1AIP2::ETV6 transcript with FLT3-ITD mutation in acute myeloid leukemia progressed from myelodysplastic syndrome

in Hematologic Malignancies

Jun Xia
Guanqun Yang
Qingling Yu
Ruiyi Zhang
Ge Li
Man Wang
Hongli Sun
Heng Chen
Lingling Wang
Ping Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1466590

1,537 views

Case Report

Published on 10 Dec 2024

Burkitt lymphoma after adult liver transplantation: a case report and literature review

in Hematologic Malignancies

Ji Zhang
Qing Chen
Shuhua Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1439137

1,610 views
1 citation

Editorial

Published on 10 Dec 2024

Editorial: Transplantation and cellular therapy in lymphomas and plasma cell disorders

in Hematologic Malignancies

Saad Z. Usmani
Nilanjan Ghosh
Peter Voorhees
Edward Copelan

Frontiers in Oncology

doi 10.3389/fonc.2024.1527836

1,103 views

2,001 articles

articles

Alectinib combined with VRCD and BV monoclonal antibody for the treatment of ALK-positive large B-cell lymphoma: a case report and literature review

Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia

Transcription factor KLF2 is associated with the dysfunctional status of NK cells and the prognosis of pediatric B-ALL patients

Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia

Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma

Real-world experiences with brentuximab vedotion-based regimens in systemic anaplastic large cell lymphoma: a multi-center retrospective study

The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis

Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML

Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes

Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment, volume II

Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma

Outcome of critically ill patients receiving systemic chemotherapy on the intensive care unit

Case report: a 3-year follow-up on nodal marginal zone lymphoma coexisting with disseminated Talaromyces marneffei infection in a non-endemic area

BTK inhibition in primary central nervous system lymphoma: mechanisms, clinical efficacy, and future perspectives

Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports

Obinutuzumab-induced acute thrombocytopenia: a case report and literature review

A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma

Chronic myelogenous leukemia coexpressing V-e16a2, V-e13a2, e13a2, and e14a2 BCR::ABL1 fusion transcripts: a case report and review of the literature

Corrigendum: Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool

Preoperative diagnosis of primary ovarian lymphoma: a case report and a decade of insights

Severe atypical skin disease in two patients with CLL/SLL after BTKi treatment - a case report and literature review

Case report: Identification of a novel TOR1AIP2::ETV6 transcript with FLT3-ITD mutation in acute myeloid leukemia progressed from myelodysplastic syndrome

Burkitt lymphoma after adult liver transplantation: a case report and literature review

Editorial: Transplantation and cellular therapy in lymphomas and plasma cell disorders